drugset / Trial / NCT00699465

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

NCT00699465

RandomizedParallel-groupDouble-blindPrevention

Summary

* To evaluate the efficacy of using IPC during the acute phase of ICH in the prevention of VTE. * To assess the safety and efficacy of additional therapy with enoxaparin. * To compare the efficacy and safety of the European and American guideline recommendations. * To provide an efficient and safe thromboprophylaxis for several weeks until the patient is able to walk.

Timeline

Start
2008-08
Primary completion
2013-07
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enoxaparin sodium Other / unclassified 20 mg Subcutaneous